Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 13 , ISSUE 3 ( July-September, 2024 ) > List of Articles

CASE REPORT

Intrapleural Fibrinolytic Therapy in Pediatric Loculated Pleural Effusion: A Case Report

Rhea P Gandhi, Sachinkumar S Dole, M S Barthwal

Keywords : Case report, Intrapleural fibrinolytic therapy, Loculated effusion, Streptokinase, Video-assisted thoracoscopic surgery

Citation Information : Gandhi RP, Dole SS, Barthwal MS. Intrapleural Fibrinolytic Therapy in Pediatric Loculated Pleural Effusion: A Case Report. Indian J Respir Care 2024; 13 (3):212-215.

DOI: 10.5005/jp-journals-11010-1135

License: CC BY-NC 4.0

Published Online: 30-09-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Pleural effusion drainage in addition to antibiotics is used for the management of empyema and complex parapneumonic effusions (CPE). Fibrinolytics aid in drainage because fibrin adhesions create loculations in the pleural space. Although open thoracotomy and video-assisted thoracoscopic surgery (VATS) are the best therapeutic modalities, their widespread use is limited by operational risk and increased costs. Thus, intrapleural fibrinolytic therapy (IPFT) must be considered before more expensive and invasive techniques. Case description: We present a case of a 10-year-old girl who presented with fever, dry cough, and loss of appetite for 2 weeks along with breathlessness for 1 week. Her chest radiograph revealed left-sided massive pleural effusion for which left tube thoracostomy was done. It was a tubercular, exudative lymphocytic effusion. The patient was advised to undergo thoracic surgery in the form of VATS with thoracotomy for failed tube drainage. Instead of subjecting her to an expensive and major surgical procedure, she was subjected to IPFT with three doses of streptokinase. There was complete resolution of the loculated pleural effusion, and she was discharged after 3 days. Conclusion: Regardless of the etiology, IPFT is an affordable option for all kinds of loculated pleural collections and needs to be presented as the first choice, even when VATS is available.


PDF Share
  1. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998;53(Suppl. 2):S65–S72. DOI: 10.1136/thx.53.2008.s65
  2. Tillet WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of post pneumonic empyema. J Thorac Surg 1951;21:275–297. DOI: 10.1016/S0096-5588(20)31273-3
  3. Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002;57:343–347. DOI: 10.1016/S0096-5588(20)31273-3
  4. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema. Chest 1996;109:1514–1519. DOI: 10.1378/chest.109.6.1514
  5. Rosen H, Nadkarni V, Theroux M, et al. Intrapleural streptokinase as adjunctive treatment for persistent empyema in pediatric patients. Chest 1993;103:1190–1193. DOI: 10.1378/chest.109.6.1514
  6. Barthwal MS. Intrapleural streptokinase in a two-year-old child with parapneumonic effusion. Indian J Chest Dis Allied Sci 2001;43:165–168.
  7. Barthwal MS. Intrapleural fibrinolytic therapy in loculated pleural effusions. J Assoc Physicians India 2020;68:32–34.
  8. Reza A, Aslam M, Gupta M, et al. Safety and efficacy of streptokinase in multiloculated pleural effusion in pediatric population. Indian J Respir Care 2022;11:4–51. DOI: 10.4103/ijrc.ijrc_137_21
  9. Aram B, Fitoon Y. Pediatric thoracic empyema—outcomes of intrapleural thrombolytics: ten years of experience. Glob Pediatr Health 2020;7:1–7. DOI: 10.1177/2333794X20928200
  10. Gowri S, Ravindra S, Ramesh S. Fibrinolytic therapy is noninferior to VATS in the treatment of stage II empyema in children in the Indian subcontinent. J Pediatr Surg 2020;55:513–517. DOI: 10.1016/j.jpedsurg.2019.08.009
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.